Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management
May 2022
in “
The Journal of Dermatology
”
hair loss SARS-CoV-2 COVID-19 Telogen Effluvium TE alopecia autoimmune alopecia alopecia areata AA oral minoxidil biotin iron supplementation antioxidant shampoo anti-inflammatory shampoo antioxidant lotion anti-inflammatory lotion vitamin D3 microneedles sandalwood photobiostimulation microinjection minoxidil iron microneedling light therapy
Studysummary This narrative review found that post-COVID-19 hair loss, particularly telogen effluvium, poses a significant mental and social burden, with minoxidil potentially aiding recovery, although more clinical research is needed to confirm its effectiveness.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →